# A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults

> **NCT05989048** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 1414 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Zavegepant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05989048
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-29
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 1414 (ACTUAL)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05989048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05989048, "A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05989048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*